Arcturus Therapeutics Holdings (ARCT) Shareholder's Equity (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) Shareholder's Equity (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Arcturus Therapeutics Holdings 217.14 Mn 5.76 Mn - 191.36 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 191.36 Mn
Dec 31, 2025 213.99 Mn
Sep 30, 2025 224.56 Mn
Jun 30, 2025 231.05 Mn
Mar 31, 2025 233.76 Mn
Dec 31, 2024 240.98 Mn
Sep 30, 2024 261.87 Mn
Jun 30, 2024 258.58 Mn
Mar 31, 2024 263.97 Mn
Dec 31, 2023 278.51 Mn
Sep 30, 2023 280.06 Mn
Jun 30, 2023 285.18 Mn
Mar 31, 2023 329.25 Mn
Dec 31, 2022 270.31 Mn
Sep 30, 2022 145.67 Mn
Jun 30, 2022 170.72 Mn
Mar 31, 2022 184.75 Mn
Dec 31, 2021 228.21 Mn
Sep 30, 2021 259.13 Mn
Jun 30, 2021 305.65 Mn